TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.

David C Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.